Sign inJoin waitlistJoin the waitlist

Herbert DuPont

Director, Center for Infectious Diseases · The University of Texas System

Credentials: · ·

History

Center for Infectious Diseases · The University of Texas System
Present
The University of Texas System
Present

Infectious Disease
Internal Medicine
UTHealth Houston School of Public Health

Research

Practice guidelines for the management of infectious diarrhea
Clinical Infectious Diseases · 2001 · 622 citations
The infectivity of Cryptosporidium parvum in healthy volunteers
New England Journal of Medicine · 1995 · First of 6 authors · 596 citations
Pathogenesis of Escherichia coli diarrhea
New England Journal of Medicine · 1971 · First of 8 authors · 576 citations

Zhi-Dong Jiang
120 papers · 19 as a resident
Charles Ericsson
87 papers
JM
John Mathewson
59 papers
Pablo Okuysen
52 papers · 4 as a resident
RH
Richard Hornick
38 papers
Kevin Garey
34 papers
LP
Larry Pickering
34 papers · 9 as a fellow
David Huang
21 papers · 15 as a resident
Hoonmo Koo
21 papers · 2 as a fellow
Javier Adachi
19 papers · 11 as a fellow
Philip Johnson
17 papers · 3 as a fellow
JF
Jose Flores
16 papers · 14 as a resident

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $16.7K · University of Texas Hlth Sci Ctr Houston
1997
Hiv-Associated Diarrhea and Wasting
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.2M · University of Texas Hlth Sci Ctr Houston
1991–1997
Hiv-Associated Diarrhea and Wasting in Zambia
National Institute of Allergy and Infectious Diseases · R55
Contact PI · $100K · University of Texas Hlth Sci Ctr Houston
1991–1992
Us/Mexican Students Susceptibility to Enteric Pathogens
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $930.8K · University of Texas Hlth Sci Ctr Houston
1986–1990

Clinical trials

Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
Principal investigator · Recruiting · Phase 1
The University of Texas Health Science Center, Houston
2023–2027
Study of the Fecal Microbiome in Patients With Parkinson's Disease
Principal investigator · Completed · Phase 1
The University of Texas Health Science Center, Houston
2019–2022
Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
Principal investigator · Terminated · Phase 2
The University of Texas Health Science Center, Houston
2017–2019
Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route
Principal investigator · Completed · Phase 1, Phase 2
The University of Texas Health Science Center, Houston
2015–2018